Making our evidence more usable – interoperability in practice
Cochrane has always aimed to provide the right evidence at the right time. As we move into a more collaborative and AI-enabled era, delivering this goal will increasingly rely on structured data. Gert van Valkenhoef, Cochrane’s Head of Data, sets out why we are improving Cochrane’s approach to data, the difference this could make, and what this means for our authors.
Breast cancer risk models fall short for women with family history
Researchers from Trinity College Dublin, St James’s Hospital, and collaborating institutions have carried out the most comprehensive review to date of tools used to estimate breast cancer risk in women with a family history of the disease.
Early birth safer for mother and baby in high blood pressure pregnancies
Planned early birth for pregnant women with high blood pressure cuts maternal complications by nearly half and reduces the risk of stillbirth, without increasing the likelihood of caesarean section, according to a new Cochrane review.
From evidence to impact: how Cochrane Thailand is turning research into practice
Discover the role Cochrane Thailand has played in closing the gap between evidence and outcomes. Designated as a WHO Collaborating Centre for Research Synthesis in Reproductive Health, the group has not only generated Cochrane reviews but has also translated those findings into national policy and clinical guidelines.
Screening modestly reduces prostate cancer deaths
Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from the previous version of the review.
What makes Cochrane’s new AI study innovative?
Cochrane has released a pre-print of the protocol for our innovative study that will test whether artificial intelligence (AI) tools can support or enhance evidence synthesis. Gerald Gartlehner from Cochrane Austria, Principal Investigator for the study, discusses how the study works, and what makes it interesting.
Anti-amyloid Alzheimer’s drugs show no clinically meaningful effect
Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has found.
Celebrating 10 years of Cochrane Russia: a decade of collaboration and impact
Image Members of Cochrane Russia at a workshop in Kazan When Cochrane Russia was established in 2015, it began as a coordinating hub fo
Simple antiseptic can reduce newborn infections
A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle- income countries, and may reduce newborn deaths.
Rupa Sarkar joins Cochrane as Editor in Chief
The Cochrane Collaboration is delighted to announce that Rupa Sarkar starts today as the new Editor in Chief.
News
News
Trusted evidence.
Informed decisions.
Better health.
Informed decisions.
Better health.
11-13 Cavendish Square
London
W1G 0AN
United Kingdom
The Cochrane Collaboration is a charity (no. 1045921) and a company limited by guarantee (no. 03044323) registered in England & Wales. VAT registration number GB 718 2127 49.
Copyright © 2026 The Cochrane Collaboration